Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AS Silvano Fashion Group Consolidated Interim Financial Report for Q3 and 09m of 2026
-
Halloween Peptide Sale 2026: Kylo Peptides Announces $1 Research Vial Sale With Orders of $200 or More
-
Sodexo - Availability of the Fiscal 2026 Universal Registration Document
-
BetMGM Marks 100 Days in Alberta
-
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq
-
The 16th China Photography Festival opens in Sanmenxia
-
Halloween THC Sale: Exhale Wellness Takes $100 Off Every $250 Order Sitewide With Code TREAT100
-
Anthropic Files S-1 as GraniteShares' AIL and ANS ETFs Await Launch
-
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
-
Anthropic Files S-1 as GraniteShares' AIL and ANS ETFs Await Launch
-
Notice of Settlement Agreement
-
KVH Industries to Host Third Quarter Conference Call on November 5, 2026
-
Israel David LLC Secures Significant Litigation Victory for Hedge Fund Manager Against Novartis
-
Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace
-
Vivakor Announces Proposed Hydrogen Plant and Fueling Station at a Texas International Airport
-
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
-
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
-
Second Intangible Cultural Heritage and Healthy Living Conference Held in Dong'e, Shandong
-
Second Intangible Cultural Heritage and Healthy Living Conference Held in Dong'e, Shandong
-
Trust Stamp Appointed Exclusive Technology Partner for AFCAS, Ghana’s National Fire Safety Digitisation Programme
-
NRC Completes Landmark Safety Review of X-energy’s Xe-100 SMR
-
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
-
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases
-
Ledyard Financial Group Earns a Record $2.5 Million, or $0.73 Per Diluted Share, in Q3 2026 and Declares Quarterly Cash Dividend of $0.21 Per Share
-
Luda Technology Group Announces Execution of Acquisition of 55% Stake in Asia AI Data Centre & Quantum Technology and Signing MOU with Huazhi Future to Explore Strategic Opportunities in AI Infras
-
Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Ty
-
EVgo to Report Third Quarter 2026 Results on November 9
-
VyOS Networks Opens Waitlist for Pre-Validated VyOS + Supermicro Routing System
-
Luda Technology Group Announces Execution of Acquisition of 55% Stake in Asia AI Data Centre & Quantum Technology and Signing MOU with Huazhi Future to Explore Strategic Opportunities in AI Infrastruc
-
ProLogium Announces Appointment of Airbus Senior Vice President Greg Ombach as Independent Director
-
BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
-
Femasys Appoints John Moorhead to Board of Directors
-
Kodiak AI Accelerates Toward Driverless Long-Haul Launch as Autonomy Readiness Measure Reaches 99%
-
Capital Clean Energy Carriers Corp. Announces Third Quarter 2026 Financial Results
-
Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
-
The Bureau of Small Projects Helps Disaster Recovery Nonprofit SBP Become Strongward
-
RentRedi Partners With Bright MLS to Connect Listing, Screening, and Property Management in One Platform
-
Invitation to the webinar on Eesti Energia’s 2026 Q3 unaudited financial results
-
Press Release Biocartis NV: Biocartis to Present Initial Development Data for Ultra-Rapid Idylla™ Breast21 Assay at SABCS 2026
-
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Offic
-
Enstar Strengthens Executive Leadership Team
-
Enstar Strengthens Executive Leadership Team
-
Ethan Allen Urges Shareholders to Elect ALL Five Company Nominees to Oversee CEO Transition and Profitable Growth
-
Sanya expands int'l tourism access via new fifth-freedom air route
-
Sanya expands int'l tourism access via new fifth-freedom air route
-
Halloween THC Sale: BudPop Launches BOO100 Code for $100 Off THC Gummies, Vapes and Drinks
-
Cat Footwear Launches Limited-Edition Collection Embellished with Crystals by Swarovski®
-
Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027
-
CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
